Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

E. Vauléon · SciRah

Researcher profile · Semantic Scholar

E. Vauléon

Share profile

E. Vauléon — researcher profile on SciRah

h-index: 31
Works: 100
Citations: 3,501

Most-cited papers

Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial
A. Omuro, A. Brandes, A. Carpentier, A. Idbaih +25 more
2022Neuro-Oncology472 citations Open access
Semantic Scholar
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
J. Edeline, E. Boucher, Y. Rolland, E. Vauléon +4 more
2012Cancer276 citations Open access
Semantic Scholar
Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers
T. Avril, E. Vauléon, É. Chevet
2017Oncogenesis251 citations Open access
Semantic Scholar
DNA methylation in glioblastoma: impact on gene expression and clinical outcome
A. Etcheverry, M. Aubry, M. de Tayrac, E. Vauléon +8 more
2010BMC Genomics227 citations Open access
Semantic Scholar
A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
K. Fizazi, A. Maillard, N. Penel, G. Baciarello +16 more
2019Annals of Oncology205 citations Open access
Semantic Scholar
Dual IRE1 RNase functions dictate glioblastoma development
S. Lhomond, T. Avril, N. Dejeans, Konstantinos Voutetakis +24 more
2018EMBO Molecular Medicine167 citations Open access
Semantic Scholar
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
X. Pivot, G. Romieu, M. Debled, J. Pierga +330 more
2019The Lancet117 citations Open access
Semantic Scholar
Human Glioblastoma Stem‐Like Cells are More Sensitive to Allogeneic NK and T Cell‐Mediated Killing Compared with Serum‐Cultured Glioblastoma Cells
T. Avril, E. Vauléon, A. Hamlat, S. Saikali +5 more
2012Brain Pathology110 citations Open access
Semantic Scholar
Overview of Cellular Immunotherapy for Patients with Glioblastoma
E. Vauléon, T. Avril, B. Collet, J. Mosser +1 more
2010Clinical and Developmental Immunology110 citations Open access
Semantic Scholar
Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions.
T. Avril, S. Saikali, E. Vauléon, A. Jary +4 more
2010Journal of Neuroimmunology90 citations
Semantic Scholar
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033
P. Bady, Sebastian Kurscheid, M. Delorenzi, T. Gorlia +18 more
2018Acta Neuropathologica81 citations Open access
Semantic Scholar
LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 “PembroRad” randomized trial
J. Bourhis, C. Sire, Y. Tao, L. Martin +16 more
2020Annals of Oncology74 citations Open access
Semantic Scholar
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.
G. Reyes‐Botero, C. Dehais, A. Idbaih, N. Martin-Duverneuil +76 more
2014Neuro-Oncology68 citations Open access
Semantic Scholar
Survival and prognostic factors in a series of adults with medulloblastomas.
L. Riffaud, S. Saikali, E. Leray, A. Hamlat +3 more
2009Journal of Neurosurgery59 citations
Semantic Scholar
Advanced chordoma treated by first-line molecular targeted therapies: Outcomes and prognostic factors. A retrospective study of the French Sarcoma Group (GSF/GETO) and the Association des Neuro-Oncologues d'Expression Française (ANOCEF).
L. Lebellec, B. Chauffert, J. Blay, A. Le Cesne +15 more
2017European Journal of Cancer55 citations
Semantic Scholar
Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial
V. Quillien, Audrey Lavenu, F. Ducray, M. Joly +15 more
2016OncoTarget55 citations Open access
Semantic Scholar
Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
M. Preusser, A. Silvani, É. Le Rhun, R. Soffietti +34 more
2021Neuro-Oncology54 citations Open access
Semantic Scholar
The 61 A/G EGF polymorphism is functional but is neither a prognostic marker nor a risk factor for glioblastoma.
E. Vauléon, N. Auger, A. Benouaich-amiel, F. Laigle-Donadey +5 more
2007Cancer Genetics and Cytogenetics52 citations
Semantic Scholar
CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma
T. Avril, A. Etcheverry, R. Pineau, J. Obacz +14 more
2017Clinical Cancer Research51 citations Open access
Semantic Scholar
A phase II randomized trial of pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN): First results of the GORTEC 2015-01 “PembroRad” trial.
Xu-Shan Sun, C. Sire, Y. Tao, L. Martin +16 more
201849 citations
Semantic Scholar
Mechanisms of immunomodulation in human glioblastoma.
T. Avril, E. Vauléon, Séverine Tanguy-Royer, J. Mosser +1 more
2011Immunotherapy48 citations
Semantic Scholar
Systemic chemotherapy for hepatocellular carcinoma in non-cirrhotic liver: a retrospective study.
J. Edeline, J. Raoul, E. Vauléon, Anne Guillygomac'h +2 more
2009World Journal of Gastroenterology45 citations Open access
Semantic Scholar
Immune genes are associated with human glioblastoma pathology and patient survival
E. Vauléon, Avril Tony, A. Hamlat, A. Etcheverry +5 more
2012BMC Medical Genomics44 citations Open access
Semantic Scholar
Rethinking Alkylating(-Like) Agents for Solid Tumor Management.
Hélène Lajous, B. Lelièvre, E. Vauléon, P. Lecomte +1 more
2019TIPS - Trends in Pharmacological Sciences41 citations Open access
Semantic Scholar
Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033
M. Klein, A. Drijver, M. J. van den Bent, Jacolien E. C. Bromberg +14 more
2020Neuro-Oncology40 citations Open access
Semantic Scholar
Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series
J. Castelli, L. Feuvret, Q. Haoming, J. Biau +14 more
2016Journal of Neuro-Oncology40 citations
Semantic Scholar
Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas
A. Alentorn, C. Dehais, F. Ducray, C. Carpentier +38 more
2015Neurology39 citations Open access
Semantic Scholar
Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local control
E. Chajon, C. Lafond, G. Louvel, J. Castelli +7 more
2013Radiation Oncology36 citations Open access
Semantic Scholar
Cementoplasty for painful bone metastases: a series of 42 cases
E. Botton, J. Edeline, Y. Rolland, E. Vauléon +5 more
2012Medical Oncology35 citations
Semantic Scholar
Characteristics of gliomas in patients with somatic IDH mosaicism
C. Bonnet, L. Thomas, D. Psimaras, F. Bielle +8 more
2016Acta Neuropathologica Communications34 citations Open access
Semantic Scholar
SNP Array Analysis Reveals Novel Genomic Abnormalities Including Copy Neutral Loss of Heterozygosity in Anaplastic Oligodendrogliomas
A. Idbaih, F. Ducray, C. Dehais, Célia Courdy +35 more
2012PLoS ONE33 citations Open access
Semantic Scholar
Guidelines for the definition of time-to-event end points in renal cell cancer clinical trials: results of the DATECAN project†.
A. Kramar, S. Négrier, R. Sylvester, S. Joniau +80 more
2015Annals of Oncology31 citations Open access
Semantic Scholar
Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients
V. Quillien, A. Carpentier, A. Gey, T. Avril +4 more
2019Cancer Immunology and Immunotherapy29 citations Open access
Semantic Scholar
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 Oligodendroglioma
S. Kacimi, C. Dehais, L. Feuvret, O. Chinot +37 more
2024Journal of Clinical Oncology22 citations
Semantic Scholar
Trabectedin for recurrent WHO grade II or III meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG).
M. Preusser, A. Silvani, É. Le Rhun, R. Soffietti +15 more
2019Journal of Clinical Oncology22 citations
Semantic Scholar
DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide
A. Etcheverry, M. Aubry, A. Idbaih, E. Vauléon +10 more
2014PLoS ONE22 citations Open access
Semantic Scholar
Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study.
E. Colomba, G. Le Teuff, T. Eisen, G. Stewart +27 more
2017European Journal of Cancer21 citations Open access
Semantic Scholar
¹³¹I-labeled lipiodol-induced interstitial pneumonia: a series of 15 cases.
S. Jouneau, E. Vauléon, S. Caulet-maugendre, É. Polard +7 more
2011Chest21 citations
Semantic Scholar
Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma.
E. Guiard, F. Clatot, C. Even, M. Perréard +4 more
2021European Journal of Cancer19 citations Open access
Semantic Scholar
Adaptive radiotherapy in head and neck cancer is required to avoid tumor underdose
J. Castelli, A. Simon, B. Rigaud, E. Chajon +7 more
2018Acta oncologica19 citations Open access
Semantic Scholar
Management of Esophageal Carcinoma Associated with Cirrhosis: A Retrospective Case-Control Analysis
F. Trivin, E. Boucher, E. Vauléon, I. Cumin +3 more
2009Journal of Oncology18 citations Open access
Semantic Scholar
Clinical validation of the CE-IVD marked Therascreen MGMT kit in a cohort of glioblastoma patients
V. Quillien, Audrey Lavenu, F. Ducray, D. Meyronet +15 more
2017Cancer Biomarkers17 citations Open access
Semantic Scholar
Multimodal management of surgery- and radiation-refractory meningiomas: an analysis of the French national tumor board meeting on meningiomas cohort
Tuan Le Van, T. Graillon, J. Jacob, E. Vauléon +28 more
2021Journal of Neuro-Oncology15 citations
Semantic Scholar
Incidence and characteristics of pseudoprogression in IDH-mutant high-grade gliomas: a POLA network study.
A. Seyve, C. Dehais, O. Chinot, A. Djelad +22 more
2022Neuro-Oncology14 citations Open access
Semantic Scholar
Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challenge
E. Vauléon, H. Mesbah, B. Laguerre, D. Gédouin +4 more
2010Cancer Chemotherapy and Pharmacology14 citations Open access
Semantic Scholar
Standard or accelerated methotrexate, vinblastine, doxorubicin and cisplatin as neoadjuvant chemotherapy for locally advanced urothelial bladder cancer: Does dose intensity matter?
D. Pouessel, S. Chevret, F. Rolland, G. Gravis +15 more
2016European Journal of Cancer13 citations
Semantic Scholar
Delayed [18F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From Radionecrosis
Hosameldin Otman, J. Farce, P. Meneret, X. Palard-Novello +11 more
2022Clinical Nuclear Medicine11 citations Open access
Semantic Scholar
Primary Leptomeningeal Gliomatosis in Children and Adults: A Morphological and Molecular Comparative Study With Literature Review.
A. Tauziède-Espariat, A. Maués De Paula, M. Pages, A. Laquérriere +11 more
2016Neurosurgery11 citations
Semantic Scholar
Acrokeratosis paraneoplastica (Bazex' syndrome) associated with metastatic squamous cell esophageal carcinoma.
G. Louvel, E. Vauléon, E. Boucher, J. Raoul
2008Journal of Clinical Oncology11 citations
Semantic Scholar
Afatinib maintenance therapy following post-operative radiochemotherapy in head and neck squamous cell carcinoma: Results from the phase III randomised double-blind placebo-controlled study BIB2992ORL (GORTEC 2010-02).
S. Racadot, Isabelle Thennevet, Yaelle Ouldbey, M. Kaminsky +16 more
2022European Journal of Cancer10 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

V. Quillien×12
Invite
V. Quillien — researcher profile on SciRah
J. Mosser×9
Invite
J. Mosser — researcher profile on SciRah
O. Chinot×9
Invite
O. Chinot — researcher profile on SciRah
F. Ducray×9
Invite
F. Ducray — researcher profile on SciRah

×8

Invite

T. Avril — researcher profile on SciRah

C. Carpentier×7

Invite

C. Carpentier — researcher profile on SciRah

D. Figarella-Branger×7

Invite

D. Figarella-Branger — researcher profile on SciRah

Invite

M. Sanson — researcher profile on SciRah

Invite

J. Raoul — researcher profile on SciRah

A. Etcheverry×6

Invite

A. Etcheverry — researcher profile on SciRah

Invite

C. Dehais — researcher profile on SciRah

D. Chiforeanu×6

Invite

D. Chiforeanu — researcher profile on SciRah